GPER/GPR30 knockout mice: effects of GPER on metabolism

Methods in Molecular Biology

Volumn 1366, Issue , 2016, Pages 489-502

  Sharma, Geetanjali ^a   Prossnitz, Eric R ^a  

^a NONE

Author keywords

Adipocyte; Adipose; Estrogen; Glucose tolerance; GPER; GPR30; Insulin resistance; Insulin sensitivity; Metabolism; Obesity; Type 2 diabetes

Indexed keywords

G PROTEIN COUPLED RECEPTOR 30; BIOLOGICAL MARKER; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCOSE BLOOD LEVEL; GPR30 PROTEIN, MOUSE; INSULIN;

ADIPOCYTE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET; PROTEIN METABOLISM; 3T3 CELL LINE; ADIPOGENESIS; ANIMAL; BLOOD; CELL SEPARATION; DEFICIENCY; DOWN REGULATION; ENERGY METABOLISM; GENE INACTIVATION; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; PHENOTYPE; PROCEDURES; TIME FACTOR; WORKFLOW;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; CELL SEPARATION; DOWN-REGULATION; ENERGY METABOLISM; GENE KNOCKOUT TECHNIQUES; GENOTYPE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MICE; MICE, KNOCKOUT; PHENOTYPE; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; TIME FACTORS; WORKFLOW;

EID: 84947797161     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-3127-9_38     Document Type: Chapter

References (30)

1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132:2087-2102
2. Sherwin R, Jastreboff AM (2012) Year in diabetes 2012: the diabetes tsunami. J Clin Endocrinol Metab 97:4293-4301
3. Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228-236
4. Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson JA (2012) The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol 212:3-12
5. Barton M (2013) Cholesterol and atherosclerosis: modulation by oestrogen. Curr Opin Lipidol 24:214-220
6. Meyer MR, Clegg DJ, Prossnitz ER, Barton M (2011) Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) 203:259-269
7. Nedungadi TP, Clegg DJ (2009) Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J Cardiovasc Transl Res 2:321-327
8. Clegg DJ (2012) Minireview: the year in review of estrogen regulation of metabolism. Mol Endocrinol 26:1957-1960
9. Mauvais-Jarvis F, Clegg DJ, Hevener AL (2013) The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34:309-338
10. Tiano JP, Mauvais-Jarvis F (2012) Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nat Rev Endocrinol 8:342-351
11. Barros RP, Gustafsson JA (2011) Estrogen receptors and the metabolic network. Cell Metab 14:289-299
12. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB- EGF. Mol Endocrinol 14:1649-1660
13. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-1630
14. Thomas P, Pang Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624-632
15. Prossnitz ER, Arterburn JB (2015) International Union of Basic and Clinical Pharmacology: G protein-coupled estrogen receptor (GPER) and its pharmacologic modulators. Pharmacol Rev 67(3):505-540
16. Barton M, Prossnitz ER (2015) Emerging roles of GPER in diabetes and atherosclerosis. Trends Endocrinol Metab 26(4):185-192
17. Prossnitz ER, Barton M (2014) Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol 389:71-83
18. Prossnitz ER, Barton M (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7:715-726
19. Dennis MK, Field AS, Burai R et al (2011) Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselec-tivity. J Steroid Biochem Mol Biol 127: 358-366
20. Dennis MK, Burai R, Ramesh C et al (2009) In vivo effects of a GPR30 antagonist. Nat Chem Biol 5:421-427
21. Bologa CG, Revankar CM, Young SM et al (2006) Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2:207-212
22. Prossnitz ER, Hathaway HJ (2015) What have we learned about GPER function in physiology and disease from knockout mice? J Steroid Biochem Mol Biol (in press).
23. Sharma G, Hu C, Brigman JL, Zhu G, Hathawa HJ, Prossnitz ER (2013) GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state. Endocrinology 154:4136-4145
24. Sharma G, Prossnitz ER (2011) Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/ GPER in pancreatic beta-cells. Endocrinology 152:3030-3039
25. Martensson UE, Salehi SA, Windahl S et al (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150:687-698
26. Romacho T, Elsen M, Rohrborn D, Eckel J (2014) Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf) 210:733-753
27. McGown C, Birerdinc A, Younossi ZM (2014) Adipose tissue as an endocrine organ. Clin Liver Dis 18:41-58
28. Exley MA, Hand L, O'Shea D, Lynch L (2014) Interplay between the immune system and adipose tissue in obesity. J Endocrinol 223:R41-R48
29. Tchernof A, Despres JP (2013) Pathophysiology of human visceral obesity: an update. Physiol Rev 93:359-404
30. Poitout V, Robertson RP (2008) Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351-36630.